In Brief: Birth Defects Prevention Act of 1997
This article was originally published in The Tan Sheet
Executive Summary
Birth Defects Prevention Act of 1997: Substitute bill S 419 passes Senate by voice vote June 12 and is referred to the House Commerce Committee. The bill would "provide surveillance, research and services aimed at prevention of birth defects," including "public awareness strategies, such as programs using folic acid vitamin supplements to prevent spina bifida." S 419 calls for the Centers for Disease Control & Prevention to collect and analyze data on birth defects, operate regional research centers and provide public education. The bill allocates $30 mil. for fiscal 1998, $40 mil. for FY 1999 and "such sums as may be necessary" for FYs 2000 and 2001. A House bill identical to the original S 419, which gives CDC less discretion, also is before House Commerce...
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning